Effect of SNX5 S226 phosphorylation on the retrograde transport of CI-M6PR. by Nao Itai (5954666)

Subjects:

Dysregulation of miR-150-5p and its target FoxO3a in atherosclerosis (AS). by Ping-yu Cai (12389929)

Subjects:

MiR-371-5p promoted the growth of pancreatic cancer cells <i>in vitro</i> and <i>in vivo</i>. by De He (497662)

Fig 5 - by Yong-Rae Kim (19797278)

Decrease of ERK phosphorylation by NOS inhibitor TRIM. by Immacolata Castellano (603814)

Decreased neutrophils in <i>MiR125a</i>^<i>-/-</i> mice. by Yuting Qin (1950118)

Mean value of ENSS and subscales. by Phu Dinh Vu (19429477)

Subjects:

Knockdown of p65 in A549 cells results in a decreased infection rate. by Janine J. Wilden (8849948)

GSH content was decreased in low glucose conditions. by Martine Emery (215947)

BA decreases DUB activity in PC cells. by Teresita Reiner (281437)

“…(<b>B</b>) DUB assay showed that BA treatment of LNCaP cells significantly decreased DUB activity at 24 and 48 h relative to control treated cells ( = 1) (*, <i>P</i><5×10⁻⁵). …”

Complex I inhibitor decreases ROS level by Zheng Li (26302)

High resolution structures visible with the 25 nm zone plate objective. by Kamal L. Nahas (13014698)

“…<p>139 CryoSXT tomograms were recorded from 107 cells using a 25 nm zone plate objective and several structures that were unrelated to HSV-1 infection were observed, including some that were not visible using the 40 nm zone plate objective. …”

Decrease of myopia progression with 0.025% atropine by Celso Marcelo da Cunha (4894324)

Klotho decreased the expression of CHOP in mouse heart. by Shuang Song (457799)

BRCA1 silencing decreases cell viability. by Pei Chen (252989)

MES transiently decreases mitochondrial membrane potential. by Shingo Matsuyama (672132)

Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

“…Representative FACS staining is shown including quantification (n = 4–5 mice per group). (E) Laquinimod decreases pathogenic potential of T cells. …”

B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

“…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”

The effect of glibenclamide on channel activity at +20, 0 and -20 mV. by Sajjad Salari (736104)

“…The addition of 50 μM glibenclamide resulted in a decreased current jump amplitude and a reduction in P_o. 100 μM glibenclamide caused a total channel inhibition at +20 and 0 mV (n = 5), but was ineffective at -20 mV. …”

Erlotinib decreases hypoxia <i>in vivo</i>. by George J. Cerniglia (261405)